R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
INMUNO-MED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
04/10/2024
Trademark type
Word
Nice classes
5
Filing date
04/05/2023
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/08/2009
First use in commerce
06/08/2009
Drawing code
4
Owner type
99
Owner location
San Salvador, SV
Examiner
THOMAS, JULIE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Quimex, S.A. de C.V.
Representatives
Jorge Espinosa GRAY ROBINSON PA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vitamin supplements
Publications
History of USPTO decisions and trademark events.
16 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2023
ALIE
ASSIGNED TO LIE
12/19/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2023
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/23/2023
GPRA
PRIORITY ACTION E-MAILED
06/23/2023
CPRA
PRIORITY ACTION WRITTEN
06/23/2023
DOCK
ASSIGNED TO EXAMINER
06/23/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/30/2023
NWAP
NEW APPLICATION ENTERED
04/08/2023
Continuous trademark protection
Get notified about every new filing that threatens INMUNO-MED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.